Emergent BioSolutions launches autoinjector to protect against chemical weapons attacks

Emergent BioSolutions ($EBS) just launched a military-grade intramuscular autoinjector device for self-administration of antidotes in the case of a chemical weapons attack. The device aims to provide militaries across the world with medical countermeasures to biological and chemicals threats. It has a needle that can penetrate not just skin, but soldiers' protective gear. The rollout of Emergard won't include the U.S., where the company intends to seek FDA approval. More from FierceMedicalDevices